CGB 0.00% 2.1¢ cann global limited

Ann: Research results lead to broader auto-immune research, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 10,644 Posts.
    lightbulb Created with Sketch. 401
    So this is the crux of the announcement-

    “The Company is now actively seeking large pharmaceutical investors or companies to partner with
    us in developing and commercialising this research.

    If they are so confident about their research results big pharma would be falling all over themselves to get on board. This will either lead to further dilution if they partner, or no interest if the results don't stack up commercially to other players with deep pockets.

    Still a long long way to go.
 
watchlist Created with Sketch. Add CGB (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.